COMPANY
Neurexis Therapeutics, Inc.
Funding and NIH signals
- NIH award NIH awarded $485K (SBIR Phase I 1R43AG094353-01A1, new, notice Sep 17, 2026); 2 NIH awards totaling $723K in the last 12 months. NIH RePORTER 1R43AG094353-01A1 (Sep 17, 2026)
Evidence (2 events)
- Sep 17, 2026 · NIH RePORTER 1R43AG094353-01A1
Organization: NEUREXIS THERAPEUTICS, INC.; City/State: AURORA, CO; Project number: 1R43AG094353-01A1; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-09-17; FY total cost (award amount): 484929; Administering IC: National Institute on Aging; Project title: Restoring AD-related neuronal dysfunction with a neuroprotective peptide; Organization type: Domestic For-Profits - Aug 27, 2026 · NIH RePORTER 5R44NS120427-04
Organization: NEUREXIS THERAPEUTICS, INC.; City/State: AURORA, CO; Project number: 5R44NS120427-04; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-27; FY total cost (award amount): 238126; Administering IC: National Institute of Neurological Disorders and Stroke; Project title: IND-enabling studies for a potent and efficient neuroprotective drug; Organization type: Domestic For-Profits
- Sep 17, 2026 · NIH RePORTER 1R43AG094353-01A1
Timeline
- Grant Government grant — SBIR: $484,929 (annual award, as published), announced Sep 17, 2026. Agency: NIH/NIA. Source: government award database. source ↗
- Grant Government grant — SBIR: $238,126 (annual award, as published), announced Aug 27, 2026. Agency: NIH/NINDS. Source: government award database. source ↗
- Grant Government grant — SBIR: $1.83M (annual award, as published), announced Aug 15, 2025. Agency: NIH/NINDS. Source: government award database. source ↗
- Grant Government grant — SBIR: $299,550 (annual award, as published), announced Apr 29, 2025. Agency: NIH/NINDS. Source: government award database. source ↗
Funding
- Government grant — SBIR: $484,929 (annual award, as published), announced Sep 17, 2026. Agency: NIH/NIA. Source: government award database. source ↗
- Government grant — SBIR: $238,126 (annual award, as published), announced Aug 27, 2026. Agency: NIH/NINDS. Source: government award database. source ↗
- Government grant — SBIR: $1.83M (annual award, as published), announced Aug 15, 2025. Agency: NIH/NINDS. Source: government award database. source ↗
- Government grant — SBIR: $299,550 (annual award, as published), announced Apr 29, 2025. Agency: NIH/NINDS. Source: government award database. source ↗
NIH awards 4
- NIH award 2R44NS120427-02A1 FY2024: $938,239 awarded for that fiscal year; activity R44 (SBIR); PI GOFORTH, ROBYN L; recipient as written: NEUREXIS THERAPEUTICS, INC., AURORA, CO. IND-enabling studies for a potent an source ↗
- NIH award 5U44NS132339-02 FY2024: $299,550 awarded for that fiscal year; activity U44 (SBIR); PI GOFORTH, ROBYN L; recipient as written: NEUREXIS THERAPEUTICS, INC., AURORA, CO. Comparative testing of tatCN19o for ne source ↗
- NIH award 1U44NS132339-01 FY2023: $299,550 awarded for that fiscal year; activity U44 (SBIR); PI GOFORTH, ROBYN L; recipient as written: NEUREXIS THERAPEUTICS, INC., AURORA, CO. Comparative testing of tatCN19o for ne source ↗
- NIH award 1R43NS120427-01A1 FY2021: $496,145 awarded for that fiscal year; activity R43 (SBIR); PI GOFORTH, ROBYN L; recipient as written: NEUREXIS THERAPEUTICS, INC., AURORA, CO. Preparing for IND-enabling safety st source ↗